Ocrevus (ocrelizumab) - Roche
Tysabri (natalizumab) - Biogen, Royalty
Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases. (PubMed, Front Neurol) - Oct 16, 2026 - No abstract available 
Journal • CNS Disorders • Multiple Sclerosis • Neuromyelitis Optica Spectrum Disorder • Rare Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42876600
 
Abdorreza Naser Moghadasi; Mahsa Ghajarzadeh; Simona Bonavita; Sreeram Ramagopalan
 
Oct 16, 2026
 
Prev Next